Abstract
In the lung, as in other anatomic sites, inflammation can be regarded as a complex, generally salutary response of the body to injurious agents. This bodily response derives from a series of interconnected cellular and molecular events acting in concert with an equally complex array of neurogenic1,2 and vasogenic factors.3–5 Principal cellular actors playing a role in the inflammatory process include polymorphonuclear leukocytes, lymphocytes, plasma cells, eosinophils, mast cells, monocytes, and macrophages. Leading molecular compounds regulating cellular responses are chemical mediators such as vasoactive amines, prostaglandins, and leukotrienes, as well as members of the kinin and complement activation system (Table 43.1).6 This chapter discusses the major forms of the inflammatory response, namely, acute and chronic inflammation, and addresses granulomatous inflammation. In addition, it covers mechanisms of response selection, innate immunity (Toll receptors), and specific cellular constituents, in particular, pulmonary alveolar macrophages and dendritic cells and their roles in antigen presentation and human leukocyte antigen (HLA)-linked diseases.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Tracey KJ. The inflammatory reflex. Nature 2002;420:853–859.
Richardson JD, Vasko MR. Cellular mechanisms of neurogenic inflammation. Pharmacol Exp Ther 2002;302:839–845.
Majno G, Palade GE. Studies on inflammation. I. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol 1961;11:571–596.
Majno G, Palade GE, Schoefl GI. Studies on inflammation. II. The site of action of histamine and serotonin along the vascular tree: a topographic study. J Biophys Biochem Cytol 1961;11:607–626.
Majno G. Commentary. Chronic inflammation: links with angiogenesis and wound healing. Am J Pathol 1998;153:1035–1039.
Kunkel SL, Strieter RM. Cytokines and chemokines in lung inflammation and injury. In Fishman AP, ed. Fishman’s Pulmonary Diseases and Disorders, 3rd ed, vol 1. New York: McGraw-Hill; 1998:315–324.
Muller WA. Leukocyte-endothelial cell interactions in the inflammatory response. Lab Invest 2002;82:521–534.
Kumar V, Abbas AK, Fausto N, ed. Robbins and Cotran Pathologic Basis of Disease, 7th ed. Philadelphia: Elsevier, 2005:47–86.
Reynolds HY, Elias JA. Pulmonary defense mechanisms against infections. In Fishman AP, ed. Pulmonary Diseases and Disorders, 3rd ed, vol 1. New York: McGraw-Hill; 1998:265–274.
Berman JS, Center DM. Lymphocyte-and macrophage-mediated inflammation in the lung. In Fishman AP, ed. Pulmonary Diseases and Disorders, 3rd ed, vol 1. New York: McGraw-Hill; 1998:275–287.
Inlay M. A response to Chapter 6 of Darwin’s Black Box. Minlay@biomail.UCSD.edu, June 2002.
Goldsby RA, Kindt TJ, Osborne BA, et al. Immunology, 5th ed. New York: W.H. Freeman; 2003:69.
Collins German Concise Dictionary, 3rd ed. Glasgow, Scotland: Harper Collins, 2006:333.
Goldstein DR. Toll like receptors and other links between innate and acquired alloimmunity. Curr Opin Immunol 2004;16:538–544.
Luke AJ, O’Neill LA. Immunity’s early-warning system. Sci Am 2005;292:38–45.
Dunne A, O’Neill LA. The interleukin-1 receptor/Toll like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2003;171:R–3.
Lazarus R, Ruby BA, Louge C, et al. Toll-like receptor 10 genetic variation is associated with asthma in two independent samples. Am J Respir Crit Care Med 2004;170:594–600.
Basu S, Fenton MJ. Toll-like receptors: function and roles in lung disease. Am J Physiol Lung Cell Mol Physiol 2004;286:L887–L892.
Pons J, Sauleda J, Regueriro V, et al. Expression of toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease. Respir Res 2006;7:64A.
Velasco G, Campo M, Manrique OJ, et al. Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Am J Respir Cell Mol Biol 2005;32:218–224.
Chen W, Kuo Lee R, Shen H, et al. Toll-like receptor 4 (TLR 4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis. Microb Pathog 2004;37:185–191.
Knapp S, Wieland CW, Florquin S, et al. Differential roles of CD14 and Toll-like receptors 4 and 2 in murine Acinetobacter pneumoniae. Am J Respir Crit Care Med 2006;173:122–129.
Corrin B, Nicholson AG. Pathology of the Lungs, 2nd ed. Philadelphia: Churchill Livingstone; 2006:1–34.
Fujii T, Hayashi S, Hogg JC, et al. Interaction of alveolar macrophages and airway epithelial cells following exposure to particulate matter produces mediators that stimulate the bone marrow. Am J Respir Cell Mol Biol 2002;27:34–41.
Abbas AK, Lichtman AH, Pober JS. Cellular and Molecular Immunology, 4th ed. Philadelphia: W.B. Saunders; 2000:22–24.
Steinman R, Cohn Z. Identification of a novel cell type in peripheral lymphoid organs of mice. J Exp Med 1973;137:1142–1162.
Satthaporn S, Eremin O. Dendritic cells (1): Biological functions. J R Coll Surg Edinb 2001;46:9–20.
Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245–252.
Holt PG. Antigen presentation in the lung. Am J Respir Crit Care Med 2000;162:S151–S156.
Randolph GJ, Beaulieu S, Lebecque S, et al. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998;282:480–483.
Godthelp T, Fokkens WJ, Kleinjan A, et al. Antigen presenting cells in the nasal mucosa of patients with allergic rhinitis during allergen provocation. Clin Exp Allergy 1996;26:677–688.
Fokkens WJ, Vroom M, Rijntjes E, et al. Fluctuation of the number of CD-1 (T6)-positive dendritic cells, presumably Langerhans cells, in the nasal mucosa of patients with an isolated grass-pollen allergy before, during, and after the grass-pollen season. J Allergy Clin Immunol 1989;84:39–43.
Tunon-de-Lara JM, Redington P, Bradding MK, et al. Dendritic cells in normal and asthmatic airways: expression of the á subunit of the high affinity immunoglobulin E receptor (Fcε RI-α). Clin Exp Allergy 1996;26:648–655
Majno G, Joris I. Cells, Tissues and Disease. Principles of General Pathology, 2nd ed. New York: Oxford University Press; 2004:442–476.
Sharma OP. Clinical diagnosis and types of granulomas. In: Cagle PT, ed. Diagnostic Pulmonary Pathology. New York: Marcel-Dekker; 2000:331–347.
Mohan H, ed. Textbook of Pathology, 5th ed. New Delhi: Jaypee Brothers, 2005:153–154.
Hasleton PS, ed. Spencer’s Pathology of the Lung, 5th Ed. New York: McGraw-Hill; 1996:1–44.
Laga AC, Allen T, Cagle PT. Usual interstitial pneumonia. In: Cagle PT, ed. Color Atlas and Text of Pulmonary Pathology. Philadelphia: Lippincott Williams & Wilkins; 2005:427–429.
Laga A, Allen T, Cagle PT. Non specific interstitial pneumonia. In: Cagle PT, ed. Color Atlas and Text of Pulmonary Pathology. Philadelphia: Lippincott Williams & Wilkins, 2005:431–432.
Laga A, Allen T, Cagle PT. Cryptogenic organizing pneumonia (idiopathic bronchiolitis obliterans organizing pneumonia). In Cagle PT, ed. Color Atlas and Text of Pulmonary Pathology. Philadelphia: Lippincott Williams & Wilkins; 2005:433–434.
Noble PN. Idiopathic pulmonary fibrosis: new insight into classification and pathogenesis usher in a new era in therapeutic approaches. Am J Respir Cell Mol Biol 2003;29:S27–S31.
Merrill WW, Reynolds HY. Bronchial lavage in inflammatory lung disease. Clin Chest Med 1983;4:71–84.
Wardlaw A. Immunologic basis of lung disease. In Wardlaw AJ, Hamid Q, eds. Textbook of Respiratory Cell and Molecular Biology. London: Martin Dunitz LTD; 2002:47–71.
Schubert MS. A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis and related disorders. Ann Allergy Asthma Immunol 2001;87:181–188.
Kappler, J, Kotzin, B, Herron L, et al. Vβ-specific stimulation of human T cells by staphylococcal toxins. Science 1989:244;811–813.
Kotb M, Norrby-Teglund A, McGeer A, et al. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002;8:1398–1404.
Krakauer T. Immune response to staphylococcal superantigens. Immunol Res 1999;20:163–173.
Paliard X, West SG, Lafferty JA, et al. Evidence for the effects of a super antigen in rheumatoid arthritis. Science 1991;253:325–329.
Hauk PJ, Wenzel SE, Trumble AE, et al. Increased T-cell receptor Vβ8+T cells in bronchoalveolar lavage fluid of subjects with poorly controlled asthma: a potential role for microbial superantigens. J Allergy Clin Immunol 1999;103:37–45.
Rammes A, Roth J, Goebeler M, et al. Myeloid-related protein (MRP) 8 and MRP14 calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997;272:9496–9502.
Bühling F, Ittenson A, Kaiser D, et al. MRP8 / MRP14, CD11b and HLA-DR expression of alveolar macrophages in pneumonia. Immunol Lett 2000;71:185–190.
Nishimura M, Mitsunaga S, Ishikawa Y, et al. Possible mechanisms underlying development of transfusion related acute lung injury: roles of anti-major histocompatibility complex class II DR antibodies. Transfusion Med 2003;13:141–147.
Schulman LL, Weinberg AD, McGregor CC, et al. Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med 2001;163:437–442.
Chalermskulrat W, Neuringer IP, Schmitz JL, et al. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation. Chest 2003;123:1825–1831.
Hoffman JA, Weinberg RI, Azen CG, et al. Human leukocyte antigen-DR expression on peripheral blood monocytes and the risk of pneumonia in pediatric lung transplant recipients. Transplant Infect Dis 2004;6:147–155.
Muehlstedt SO, Lyte M, Rodriguez JL. Increased IL-10 production and HLA-DR suppression in the lungs of injured patients precede the development of nosocomial pneumonia. Shock 2002;17:443–450.
Ye Q, Finn PW, Sweeney R, et al. MCH class II-associated invariant chain isoforms regulate pulmonary immune responses. J Immunol 2003;170:1473–1480.
Tsybalova LM, Popova TL, Karpukhin GI. HLA system antigens in persons with differing susceptibilities to the causative agents of acute respiratory diseases. Zh Mikrobiol Epidemiol Immunobiol 1989;10:64–68.
Selman LM, Chapela R, Salas J, et al. Hypersensitivity pneumonitis: clinical approach and an integral concept about its pathogenesis. A Mexican point of view. In Selman-Lama M, Barrios R, eds. Interstitial Pulmonary Diseases: Selected Topics. Boston: CRC Press; 1991:171–195.
Wilson BD, Sternick JL, Yoshizawa Y, et al. Experimental murine hypersensitivity pneumonitis: multigenic control and influence by genes within the I-B subregion of the H-2 complex. J Immunol 1982;129:2160–2163.
Rittner G, Sennenkamp J, Mollenhauer E, et al. Pigeons breeder’s lung association with HLA-DR3. Tissue Antigens 1983;21:374–379.
Ando M, Hirayama K, Soda K, et al. HLA-DQw3 in Japanese summer-type hypersensitivity pneumonitis induced by Trichosporon cutaneum. Am Rev Respir Dis 1989;140:948–950.
Park MH, Kim YW, Yoon HI, et al. Association of HLA class I antigens with diffuse panbronchiolitis. 1999;159:526–529.
Keicho N, Tokunaga K, Nakata K, et al. Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis. Am J Respir Crit Care Med 1998;158:846–850.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC.
About this chapter
Cite this chapter
Fraire, A.E. (2008). Inflammation. In: Zander, D.S., Popper, H.H., Jagirdar, J., Haque, A.K., Cagle, P.T., Barrios, R. (eds) Molecular Pathology of Lung Diseases. Molecular Pathology Library, vol 1. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72430-0_43
Download citation
DOI: https://doi.org/10.1007/978-0-387-72430-0_43
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-72429-4
Online ISBN: 978-0-387-72430-0
eBook Packages: MedicineMedicine (R0)